| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/27/1994 | EP0485471B1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
| 04/27/1994 | CN1085912A Peptide compounds |
| 04/27/1994 | CN1085911A Peptide compounds |
| 04/26/1994 | US5306708 Antibiotic agent |
| 04/26/1994 | CA1328949C Peptide and anti-dementia agent |
| 04/26/1994 | CA1328948C Polypeptide compounds |
| 04/20/1994 | EP0593094A2 Pulmonary surfactant protein and related polypeptide |
| 04/20/1994 | EP0593058A2 Peptide-surfactant, production process thereof and microorganisms producing the same |
| 04/20/1994 | EP0592791A2 Tricyclic compounds and peptide derivatives thereof |
| 04/20/1994 | EP0592634A1 Inhibitor of protein kinase c |
| 04/20/1994 | EP0592553A1 Pla2 inhibitory compounds |
| 04/20/1994 | EP0592529A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 04/20/1994 | EP0592512A1 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| 04/20/1994 | EP0433345B1 Peptide synthesis method and solid support for use in the method |
| 04/20/1994 | CN1085563A Novel peptides, the preparation and use thereof |
| 04/20/1994 | CN1085449A Improvements in or relating to vaccines |
| 04/19/1994 | US5304642 Pristinaymcinia or virginiamycin derivatives and their preparation |
| 04/19/1994 | US5304633 Fragments of lactoferrin having potent antimicrobial activity |
| 04/19/1994 | US5304632 Neuropeptides of the tachykinin family |
| 04/14/1994 | WO1994008014A1 Polypeptides involved in streptogramin biosynthesis, nucleotide sequences coding for said polypeptides and use thereof |
| 04/14/1994 | WO1994007914A1 Allosteric modulators of the nmda receptor |
| 04/14/1994 | WO1994007593A1 Improved sensor membranes |
| 04/14/1994 | WO1994007523A1 Antimicrobial peptides |
| 04/14/1994 | WO1994007519A1 Growth hormone releasing peptides |
| 04/14/1994 | WO1994007518A1 Anaphylatoxin receptor ligands containing lipophilic residues |
| 04/14/1994 | WO1994007517A1 Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
| 04/14/1994 | WO1993025576A3 Peptides having platelet-derived growth factor (pdgf) activity |
| 04/14/1994 | CA2282888A1 Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding peptides |
| 04/14/1994 | CA2145996A1 Improved sensor membranes |
| 04/14/1994 | CA2124566A1 Allosteric modulators of the nmda receptor |
| 04/13/1994 | EP0592026A1 Method for determining antigenic reactivity in urine |
| 04/13/1994 | EP0591431A1 Hepatitis c virus (hcv) polypeptides |
| 04/12/1994 | US5302507 Antigenic peptide for detecting anti-hepatitis C virus antibodies and use thereof |
| 04/12/1994 | CA1328540C Cyclic anticoagulant peptides |
| 04/06/1994 | EP0590152A1 Peptides with tachykinin antagonist activity |
| 04/06/1994 | EP0590070A1 Broad spectrum antimicrobial compounds and methods of use |
| 04/06/1994 | EP0590055A1 M-protein peptides of influenza virus as antiviral agents |
| 04/06/1994 | EP0590044A1 Composition and treatment with biologically active peptides having c-terminal substitutions |
| 04/06/1994 | EP0590006A1 Synthetic pulmonary surfactant peptides |
| 04/06/1994 | EP0589993A1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 04/06/1994 | EP0589989A1 USE OF $g(b)-CELL TROPIN (ACTH 22-39) ANTAGONISTS IN THE TREATMENT OF HYPERINSULINAEMIA AND ASSOCIATED DISEASES |
| 04/06/1994 | EP0589961A1 Assay systems for neurotrophin activity |
| 04/06/1994 | EP0383856B1 Use of peptides for inhibiting blood vessel blockage |
| 04/05/1994 | US5300651 Indole NH-group blocked with tert-butoxycarbonyl, a-amino group with 9-fluoroenzylmethoxycarbonyl |
| 04/05/1994 | US5300629 Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees |
| 04/05/1994 | US5300492 Suppressing levels of sex hormones in male or female mammals |
| 04/05/1994 | US5300434 Determing collagen degradation in vivo |
| 04/05/1994 | US5300425 Providing antibodies which are ivnerse images of diverse mimotpes |
| 03/31/1994 | WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | WO1994006471A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006453A1 Bradykinin antagonists containing aliphatic amino acids in the 5-position |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994006450A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | WO1994000489A3 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 03/31/1994 | CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | CA2144773A1 Brain enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
| 03/30/1994 | EP0589719A1 Modified platelet factor-4 |
| 03/30/1994 | EP0589181A2 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 03/30/1994 | EP0589004A1 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 03/30/1994 | EP0321496B1 Temperature correlated force and structure development of elastin polytetrapeptides and polypentapeptides |
| 03/30/1994 | CN1084563A Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
| 03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
| 03/29/1994 | US5298621 Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same |
| 03/29/1994 | US5298596 Peptides and analogues and mixtures thereof for detecting and eliciting antibodies to rubella virus |
| 03/29/1994 | US5298490 Tetra and penta-peptides useful in regulating the immune system |
| 03/29/1994 | US5298410 Conjugated with superoxide dismutase protein |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/26/1994 | CA2106629A1 Modified platelet factor-4 |
| 03/23/1994 | EP0588122A1 Improved antibodies to plasmodium falciparum |
| 03/23/1994 | EP0587799A1 Inhibitors of cathepsin g and elastase for preventing connective tissue degradation |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587719A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO) |
| 03/23/1994 | EP0464124B1 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 03/22/1994 | US5296468 GnRH analogs |
| 03/22/1994 | US5296354 Kit for the specific assay of angiotensin II |
| 03/17/1994 | WO1994005788A1 Neurotrophic peptide |
| 03/17/1994 | WO1994005696A1 Novel peptide, and antithrombotic agent, anticoagulant for extracorporeal circulation, cell fusion inhibitor, cancer metastasis inhibitor, protective for platelet preparation for transfusion and pack of platelet preparation for transfusion |
| 03/17/1994 | WO1994005692A1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein |
| 03/17/1994 | WO1994005311A1 Retro-, inverso-, and retro-inverso synthetic peptide analogues |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005304A1 Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
| 03/17/1994 | WO1994002507A3 Methods for detecting pre-clinical iddm |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2122912A1 Novel peptides, and platelet aggregation-inhibiting agents, blood coagulation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis inhibiting agents, agents for protecting platelet preparations for blood transfusion and platelet preparation packs for transfusion using said novel peptides |
| 03/16/1994 | EP0586618A1 The use of nucleic acid analogues in diagnostics and analytical procedures. |
| 03/16/1994 | EP0586613A1 Bradykinin antagonists |
| 03/16/1994 | EP0586607A1 HEREGULINS (HRGs), BINDING PROTEINS OF P185?erb2 |
| 03/16/1994 | EP0586474A1 Peptide nucleic acids |
| 03/16/1994 | EP0413731B1 Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
| 03/15/1994 | US5294720 1,4-diamino-2,3-dihydroxybutanes |
| 03/15/1994 | US5294609 DNA gyrase inhibitors and pharmaceutical preparations therefor |
| 03/15/1994 | US5294605 Antimicrobial, antitumor |
| 03/15/1994 | CA1327869C Ribonucleotide reductase inhibitors |
| 03/09/1994 | EP0585444A1 Hepatoma treatment with somatostatin analogs |
| 03/09/1994 | EP0585412A1 Increasing blood-brain barrier permeability with permeabilizer peptides |
| 03/09/1994 | EP0437487B1 Targetting agents |